Skip to main content
  • 122 Accesses

Abstract

Theophrastus Bombastus von Hohenheim, 1493–1541, the Swiss physician who called himself Paracelsus, was the first clinician in Europe to suggest the prescription of chemical therapeutics in medicine (Figure 1). Paracelsus sharply broke with traditional beliefs when he applied his interest in alchemy and metals to the treatment of his patients. In so doing, he earned himself the title ‘father of pharmacology’ [1]. Zinc sulphate (sal vitrioli) was part of his pharmaceutical arsenal and was termed gilla Theophrasti [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Petrucelli RJ. The renaissance. The fifteenth and sixteenth centuries. In: Lyons AS, Petrucelli RJ, eds. Medicine, an Illustrated History. New York: Abrahams; 1978:376–377.

    Google Scholar 

  2. Pereira J. De beginselen der materia medica en der therapie, voor Nederland bewerkt door LCEE Fock. Amersfoort: WJ van Bommel van Vloten; 1849.

    Google Scholar 

  3. Gaubius HD. Adversariorum varii argumenti. Luna fixa Ludemanni. Leiden: Luchtmans; 1771.

    Google Scholar 

  4. Hoogenraad TU. Luna fixa Ludemanni or the introduction of oral zinc therapy in official medicine. Trace Elem Med. 1984;1:47–49.

    Google Scholar 

  5. Schroeder van der Kolk JLC. Bau und Functionen der Medulla spinalis und oblongata und nächste Ursache und rationelle Behandlung der Epilepsie. Braunschweig: Vieweg und Sohn; 1859.

    Google Scholar 

  6. Herpin T. Du prognostic et du traitement curatif de l’épilepsie. Paris: JB Ballière; 1852.

    Google Scholar 

  7. Schouwink G. The continuing story of copper and zinc. In: Scheinberg IH, Walshe JM, eds. Orphan Diseases and Orphan Drugs. Manchester: Manchester University Press; 1986:56–62.

    Google Scholar 

  8. Dick AT. Copper toxicosis in sheep [dissertation]. Melbourne: University of Melbourne; 1954.

    Google Scholar 

  9. Hoogenraad TU, Koevoet R, de Ruyter Korver EGWM. Oral zinc sulphate as long-term treatment in Wilson’s disease (hepatolenticular degeneration). Eur Neurol. 1979;18:205–211.

    Article  PubMed  CAS  Google Scholar 

  10. Hoogenraad TU, Van den Hamer CJ, Koevoet R, de Ruyter Korver EG. Oral zinc in Wilson’s disease [letter]. Lancet. 1978;2:1262–1263.

    Article  PubMed  CAS  Google Scholar 

  11. Milanino R, Deganello A, Marrella M et al. Oral zinc as initial therapy in Wilson’s disease: two years of continuous treatment in a 10-year-old child. Acta Paediatr. 1992;81:163–166.

    Article  PubMed  CAS  Google Scholar 

  12. Prasad AS. Deficiency of zinc in man and its toxicity. In: Prasad AS, Oberleas D, eds. Trace Elements in Human Health and Disease. Vol.2. New York: Academic Press; 1976:1–20.

    Google Scholar 

  13. Barnes PM, Moynahan EJ. Zinc deficiency in acrodermatitis enteropathica: multiple dietary intolerance treated with synthetic diet. Proc R Soc Med. 1973;66:327–329.

    PubMed  CAS  Google Scholar 

  14. Leonard A, Gerber GB. Toxicity of essential and beneficial metal ions: zinc. In: Berthon G, ed. Handbook of Metal-Ligand Interactions in Biological Fluids. New York: Marcel Dekker; 1995:705–708.

    Google Scholar 

  15. Rainsford KD, Whitehouse MW. Anti-ulcer activity of a slow-release zinc complex, zinc monoglycerolate (Glyzinc). J Pharm Pharmacol. 1992;44:476–482.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Hoogenraad, T.U. (1998). History of zinc therapy. In: Rainsford, K.D., Milanino, R., Sorenson, J.R.J., Velo, G.P. (eds) Copper and Zinc in Inflammatory and Degenerative Diseases. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3963-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3963-2_1

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5757-8

  • Online ISBN: 978-94-011-3963-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics